Cell-Mediated Immune Responses of Healthy Laboratory Volunteers to Sonicate Antigens Prepared from the Most Prevalent Strains of Mycobacterium tuberculosis from South India Harboring a Single Copy of IS6110

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 6, 2003, Pages 1149-1152

  Rajavelu, Priya ^a   Das, Sulochana D ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 12; TUBERCULIN;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; GENE INSERTION SEQUENCE; HEALTH STATUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IN VITRO STUDY; INDIA; LABORATORY; LYMPHOCYTE PROLIFERATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PREVENTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; T LYMPHOCYTE; VOLUNTEER;

ANTIGENS, BACTERIAL; DNA TRANSPOSABLE ELEMENTS; HUMANS; IMMUNITY, CELLULAR; INDIA; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0345257023     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.6.1149-1152.2003     Document Type: Article

References (23)

1. Almeida, M. G. B., S. Chitale, and I. Boutsikakis. 1998. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement of IFN-γ and primed lymphocytes. J. Exp. Med. 160:4490-4499.
2. Anderson, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536-2544.
3. Bertagnoli, M. M., B.-Y. Lin, D. Young, and S. H. Herrmann. 1992. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149:3778-3783.
4. Cher, D. J., and T. R. Mosmann. 1987. Two types of murine helper T cell clones. II. Delayed type hypersensitivity is mediated by Th1 clones. J. Immunol. 138:3688-3694.
5. Cooper, A. M., J. Margram, J. Ferrante, and I. M. Orme. 1997. IL-12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:39-45.
6. Das, S., C. N. Paramasivan, D. B. Lowrie, R. Prabhakar, and P. R. Narayanan. 1995. IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India. Tuber. Lung Dis. 76:550-554.
7. Das, S. D., P. R. Narayanan, C. Kolapan, and M. J. Colston. 1998. The cytokine response to bacille Calmette Guerin vaccination in South India. Int. J. Tuberc. Lung Dis. 2:836-843.
8. Demissie, A., P. Ravn, J. Olobo, T. M. Doherty, T. Eguale, M. Geletu, W. Hailu, P. Andersen, and S. Britton. 1999. T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their house contacts. Infect. Immun. 67:5967-5971.
9. Fine, P. E. M. 1989. The BCG story: lessons from the past and implications for the future. Rev. Infect. Dis. 12:353-359.
10. Flynn, J. A., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for IFN-γ in resistance to Mycobacterium tuberculosis. J. Exp. Med. 178:2249-2251.
11. Katial, R. K., J. Hershey, T. Purohit-Seth, J. T. Belisle, P. J. Brennan, J. S. Spencer, and R. Engler. 2001. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture. Clin. Diagn. Lab. Immunol. 8:339-345.
12. Ladel, C. H., G. Szalay, D. Reidel, and S. H. E. Kaufmann. 1997. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages. Infect. Immun. 65:1936-1938.
13. Lindblad, E. B., M. J. Ellay, R. Silva, R. Appelberg, and P. Andersen. 1997. Adjuvant modulation of responses to tuberculosis subunit vaccines. Infect. Immun. 65:623-629.
14. Mustafa, A. S. 2002. Development of new vaccines and diagnostic reagents against tuberculosis. Mol. Immunol. 39:113-119.
15. Narayanan, S., S. Das, R. Garg, L. Hari, V. B. Rao, T. R. Frieden, and P. R. Narayanan. 2002. Molecular epidemiology of tuberculosis in a rural area of high prevalence in South India: implications for disease control and prevention. J. Clin. Microbiol. 40:4785-4788.
16. Orme, I. M. 1999. Beyond BCG: the potential for a more effective B vaccine. Mol. Med. Today 5:487-492.
17. Orme, I. M. 1988. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance, in mice inoculated with killed mycobacterial vaccines. Infect. Immun. 56:3310-3312.
18. Pal, P. G., and M. A. Horwitz. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:4781-4792.
19. Raja, A., K. R. Uma Devi, B. Ramalingam, and P. J. Brennan. 2002. Immunoglobulin G, A, and M responses in serum and circulating immune complexes elicited by the 16-kilodalton antigen of Mycobacterium tuberculosis. Clin. Diagn. Lab. Immunol. 9:308-312.
20. Sampson, S. L., R. M. Warren, M. Richardson, G. D. Van der Spuy, and P. D. Van Helden. 1999. Disruption of coding regions by IS6110 insertion in Mycobacterium tuberculosis. Tuber. Lung Dis. 79:349-359.
21. Siddiqui, S. M., I. M. Orme, and R. K. Saxena. 2000. Efficacy of culture filtrate protein preparations from Indian isolates of Mycobacterium tuberculosis to activate T cells derived from healthy donors. Int. J. Tuberc. Lung Dis. 4:980-987.
22. Wisher, M. L., C. Hagan, R. Prestidge, A. U. Wells, and G. Murison. 1999. Human in vitro immune responses to Mycobacterium tuberculosis. Tuber. Lung Dis. 79:371-377.
23. Worku, S., and D. F. Hoft. 2000. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of Bacille Calmette-Guerin. Clin. Infect. Dis. 30(Suppl. 3):8257-8261.